JP2024502670A5 - - Google Patents
Info
- Publication number
- JP2024502670A5 JP2024502670A5 JP2023542963A JP2023542963A JP2024502670A5 JP 2024502670 A5 JP2024502670 A5 JP 2024502670A5 JP 2023542963 A JP2023542963 A JP 2023542963A JP 2023542963 A JP2023542963 A JP 2023542963A JP 2024502670 A5 JP2024502670 A5 JP 2024502670A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- amino acid
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110065290 | 2021-01-18 | ||
| CN202110065290.8 | 2021-01-18 | ||
| PCT/CN2022/072265 WO2022152285A1 (zh) | 2021-01-18 | 2022-01-17 | Garp蛋白抗体及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502670A JP2024502670A (ja) | 2024-01-22 |
| JP2024502670A5 true JP2024502670A5 (https=) | 2025-01-27 |
Family
ID=82446943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542963A Pending JP2024502670A (ja) | 2021-01-18 | 2022-01-17 | Ｇａｒｐタンパク質抗体及びその適用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240117034A1 (https=) |
| EP (1) | EP4279509A4 (https=) |
| JP (1) | JP2024502670A (https=) |
| KR (1) | KR20230169936A (https=) |
| CN (1) | CN116710125A (https=) |
| AU (1) | AU2022207029A1 (https=) |
| BR (1) | BR112023014319A2 (https=) |
| CA (1) | CA3208624A1 (https=) |
| IL (1) | IL304453A (https=) |
| TW (1) | TW202241955A (https=) |
| WO (1) | WO2022152285A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025524957A (ja) * | 2022-07-29 | 2025-08-01 | アッヴィ・バイオセラピューティクス・インコーポレイテッド | 抗ＧＡＲＰ－ＴＧＦ－β１／ＰＤ－１併用療法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| ES2860952T3 (es) * | 2013-08-01 | 2021-10-05 | Univ Catholique Louvain | Proteína anti-garp y usos de la misma |
| WO2016125017A1 (en) * | 2015-02-03 | 2016-08-11 | Universite Catholique De Louvain | Anti-garp protein and uses thereof |
| DK3354729T5 (da) * | 2015-09-24 | 2024-09-30 | Daiichi Sankyo Co Ltd | Anti-garp-antistof |
| CA3055555A1 (en) * | 2016-03-11 | 2017-09-14 | Scholar Rock, Inc. | Tgf.beta.1-binding immunoglobulins and use thereof |
| CN110049773A (zh) * | 2016-07-14 | 2019-07-23 | 供石公司 | TGFβ抗体、方法和用途 |
| GB201707561D0 (en) * | 2017-05-11 | 2017-06-28 | Argenx Bvba | GARP-TGF-beta antibodies |
| US20230192867A1 (en) * | 2020-05-15 | 2023-06-22 | Bristol-Myers Squibb Company | Antibodies to garp |
-
2022
- 2022-01-17 BR BR112023014319A patent/BR112023014319A2/pt unknown
- 2022-01-17 TW TW111101854A patent/TW202241955A/zh unknown
- 2022-01-17 WO PCT/CN2022/072265 patent/WO2022152285A1/zh not_active Ceased
- 2022-01-17 JP JP2023542963A patent/JP2024502670A/ja active Pending
- 2022-01-17 KR KR1020237027472A patent/KR20230169936A/ko active Pending
- 2022-01-17 CN CN202280010421.5A patent/CN116710125A/zh active Pending
- 2022-01-17 US US18/272,826 patent/US20240117034A1/en active Pending
- 2022-01-17 EP EP22739160.4A patent/EP4279509A4/en active Pending
- 2022-01-17 AU AU2022207029A patent/AU2022207029A1/en active Pending
- 2022-01-17 CA CA3208624A patent/CA3208624A1/en active Pending
-
2023
- 2023-07-13 IL IL304453A patent/IL304453A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210024635A1 (en) | Anti-wt1/hla-specific antibodies | |
| JP2021516974A5 (https=) | ||
| JP2021515566A5 (https=) | ||
| JP2021533726A5 (https=) | ||
| JP2021516973A5 (https=) | ||
| JP2021515565A5 (https=) | ||
| JP2021515568A5 (https=) | ||
| JP2024522360A5 (https=) | ||
| JP2021516975A5 (https=) | ||
| JP2021516976A5 (https=) | ||
| JP2021526022A5 (https=) | ||
| KR20190117493A (ko) | 항 pd-1 항체 및 그의 용도 | |
| EP4039705A1 (en) | Antibody targeting bcma, bispecific antibody, and use thereof | |
| JP2020528750A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| KR20170010764A (ko) | 신규한 항-ｒｎｆ43 항체 및 사용 방법 | |
| JP2022533538A5 (https=) | ||
| JP2020522281A5 (https=) | ||
| RU2019104980A (ru) | Анти-icos антитела | |
| JP2024540148A5 (https=) | ||
| JP2020533965A5 (https=) | ||
| WO2023040940A1 (zh) | Pvrig/tigit结合蛋白联合免疫检查点抑制剂用于治疗癌症 | |
| JP2021512652A5 (https=) | ||
| JP2020531003A5 (https=) | ||
| JP2024546939A (ja) | ヒトｃｄ７３と結合する抗体、その製造方法と使用 |